Der Markt für menschliche Mikrobiome wird bis 2028 voraussichtlich 2.921,68 Millionen US-Dollar erreichen, gegenüber 718,95 Millionen US-Dollar im Jahr 2021; Es wird geschätzt, dass es im Zeitraum 20212028 mit einer jährlichen Wachstumsrate von 22,2 % wachsen wird. Die menschliche Mikrobiota besteht aus Billionen symbiotischer Mikrobenzellen, die jeder Mensch beherbergt, hauptsächlich Bakterien im Darm. Die Mikroben, darunter Bakterien, Pilze und Viren, sind die Krankheitserreger, die sich im Laufe der Zeit ansammeln, und der Lebensraum im Darm verändert ihre genetischen Aktivitäten und Stoffwechselprozesse, was zu einer abnormalen Immunantwort gegen die Substanzen und Gewebe führt, die normalerweise darin vorhanden sind der menschliche Körper. Weltweit wurden mehrere Mikrobiomprojekte gestartet, um die Rolle dieser Symbionten und ihre Auswirkungen auf die Gesundheit des menschlichen Wirts zu verstehen. Das Wachstum des Marktes für menschliche Mikrobiome wird auf Faktoren wie das zunehmende Auftreten von Zivilisationskrankheiten, die zunehmende Konzentration auf Therapien mit menschlichen Mikrobiomen und wachsende technologische Fortschritte in der Metagenomik und der Sequenzierung der nächsten Generation zurückgeführt. Allerdings behindern strenge staatliche Richtlinien und fehlende Kenntnisse über detaillierte Untersuchungen das Marktwachstum.
Lukrative Regionen für den Markt für menschliche Mikrobiome
Markteinblicke
Steigendes Auftreten von Zivilisationskrankheiten
In den letzten Jahrzehnten sind Forscher gekommen Klarheit über den Zusammenhang zwischen dem menschlichen Mikrobiom und Zivilisationskrankheiten wie Krebs, Diabetes, Fettleibigkeit und Depressionen gewinnen. Veränderungen im Lebensstil und in gesellschaftlichen Normen beeinflussen das Mikrobiom in jeder Lebensphase. Eine Veränderung des menschlichen Mikrobioms kann dazu beitragen, solche Zivilisationskrankheiten zu beseitigen. Nach Angaben der Weltgesundheitsorganisation waren im Jahr 2016 13 % der Weltbevölkerung (Erwachsene) fettleibig. Laut der 2016 veröffentlichten Studie The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation leben Mikroben wirken im menschlichen Magen-Darm-Trakt als endokrines Organ, dessen Zusammensetzung und Funktionalität zur Entstehung von Fettleibigkeit beitragen. Daher ist die Stuhl-/Darm-Mikrobiomtransplantation (GMT), bei der Stuhl von einem gesunden Spender auf den Patienten übertragen wird, eine mögliche Behandlung von Fettleibigkeit.
Diabetes ist einer der globalen Gesundheitsnotfälle des 21. Jahrhunderts. Nach Angaben der International Diabetes Federation (IDF) lag die Zahl der an Diabetes erkrankten Menschen in Nordamerika im Jahr 2017 bei etwa 46 Millionen und wird bis 2045 voraussichtlich auf 62 Millionen ansteigen, d. h. bei einer Krankheitsprävalenz von etwa 35 % Prognosezeitraum. Die verringerten Werte von Firmicutes Clostridia weisen auf das Mikrobiom von Patienten mit Diabetes hin, die Butyrat produzierende Bakterien und ein erhöhtes Verhältnis von Bacteroidetes: Firmicutes. Somit kann Diabetes sowohl verhindert als auch behandelt werden, indem das Mikrobiom durch die Verabreichung von Präbiotika, Probiotika und Stuhltransplantation verändert wird. Daher treibt das zunehmende Auftreten chronischer Zivilisationskrankheiten das Wachstum des Marktes für menschliche Mikrobiome voran.
Produktbasierte Erkenntnisse
Basierend auf dem Produkt ist der Markt für menschliche Mikrobiome in Lebensmittel und medizinische Lebensmittel unterteilt , Probiotika, Präbiotika, Medikamente, Diagnosegeräte und Nahrungsergänzungsmittel. Es wird erwartet, dass das Probiotika-Segment im Jahr 2021 den größten Marktanteil halten wird, und das Präbiotika-Segment wird im Prognosezeitraum voraussichtlich die höchste CAGR auf dem Markt verzeichnen.
Markt für menschliche Mikrobiome nach Produkt 2021 und 2028
Berichtsberichterstattung
Krankheitsbasierte Erkenntnisse
Der Markt für menschliche Mikrobiome ist nach Krankheiten unterteilt in Diabetes, Krebs, Autoimmunerkrankungen, Fettleibigkeit, psychische Störungen, und andere Krankheiten. Der Markt für das menschliche Mikrobiom entsteht aufgrund der zunehmenden Häufigkeit von Zivilisationskrankheiten wie Krebs und Diabetes. Es wird erwartet, dass das Adipositas-Segment im Jahr 2021 den größten Marktanteil halten wird, während das Diabetes-Segment im Prognosezeitraum voraussichtlich die höchste CAGR verzeichnen wird.
Anwendungsbasierte Erkenntnisse
Der Markt für menschliche Mikrobiome ist je nach Anwendung in Diagnostika und Therapeutika unterteilt. Es wird prognostiziert, dass das Therapeutika-Segment im Jahr 2021 einen größeren Marktanteil halten wird, und es wird darüber hinaus geschätzt, dass es im Prognosezeitraum eine höhere CAGR verzeichnen wird.
Strategische Einblicke
Produkteinführungen und -zulassungen sind die allgemein angenommenen Strategien von Unternehmen zur Erweiterung ihrer globalen Präsenz und ihres Produktportfolios. Unternehmen auf dem Markt für menschliche Mikrobiome konzentrieren sich auf die Strategie der Zusammenarbeit, um ihren Kundenkreis zu vergrößern, was ihnen wiederum ermöglicht, ihren Markennamen auf der ganzen Welt aufrechtzuerhalten.
Markt für menschliche Mikrobiome nach Produkt
< ul>
Markt für menschliches Mikrobiom nach Krankheit
- Fettleibigkeit
- Diabetes
- Autoimmunerkrankung Störungen
- Krebs
- Psychische Störungen
- Andere
Markt für menschliches Mikrobiom nach Anwendung
- Therapeutika
- Diagnostika
Markt für menschliche Mikrobiome nach Geografie
- Nordamerika
- USA
- Kanada
- Mexiko
- Europa
- Frankreich
- Deutschland
< li>Italien - Großbritannien
- Spanien
- Restliches Europa
- Südafrika
- Saudi-Arabien
- VAE
- Übriger Naher Osten und Afrika
- Brasilien
- Argentinien
- Übriges Süd- und Mittelamerika
Unternehmensprofile
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Synthetic Biologics Inc.
- DuPont
- MaaT Pharma
- Eligo Bioscience
- AOBiome LLC
- Kaleido
- Seres Therapeutics
< li>Merck & Co. Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Asia Pacific human microbiome market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The rise in the collaborations among the Asian countries and Western countries for the research activities and the extensive genomic research in China are to likely drive the human microbiome market in the forecast period. In May 2018, The Conference on Human Microbiome and Chronic Disease, hosted by the Institute of Microbiology, Chinese Academy of Sciences and Chinese Society of Biotechnology was held in China National Convention Center at Beijing. The aim was to promote research human microbiome and related technology. Thus, there is a huge potential for human microbiome market in the region during the forecast period owing to the above-mentioned factors.
The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.
The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body.
The List of Companies - Human Microbiome Market
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Synthetic Biologics Inc.
- DuPont
- MaaT Pharma
- Eligo Bioscience
- Merck & Co. Inc
- AOBiome LLC
- Kaleido
- Seres Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Aug 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Aug 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Aug 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)